Nephros (FRA:NPJP) Debt-to-Revenue : 0.12 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Nephros Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Nephros's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.37 Mil. Nephros's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.20 Mil. Nephros's annualized Revenue for the quarter that ended in Mar. 2024 was €12.96 Mil. Nephros's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.12.

Nephros Debt-to-Revenue Historical Data

The historical data trend for Nephros's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nephros Debt-to-Revenue Chart

Nephros Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

0.25

0.10

0.11

0.13

Nephros Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial															0.06	0.06	0.05	0.14	0.12

Competitive Comparison of Nephros's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Nephros's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nephros's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nephros's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nephros's Debt-to-Revenue falls into.

Nephros Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Nephros's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.409	+	1.275)	/	13.056
	=	0.13

Nephros's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.37	+	1.202)	/	12.96
	=	0.12

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.

Nephros Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nephros's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nephros (FRA:NPJP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nephros Inc (FRA:NPJP) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

NEPH:USA

Address

380 Lackawanna Place, South Orange, NJ, USA, 07079

Website

https://www.nephros.com

Nephros Inc is a commercial-stage company that develops and sells high performance water solutions to the medical and commercial markets. In medical markets, it sell water filtration products and waterborne pathogen detection products. In commercial markets, the company manufacture and sell water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The operating segments of the group are Water Filtration, Pathogen Detection and Renal Products of which key revenue is derived from Water Filtration segment.

Nephros (FRA:NPJP) Headlines

No Headlines